drugset / Trial / NCT01949766

Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

NCT01949766

Expanded access No longer available University of Pittsburgh

Summary

This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycerol phenylbutyrate Other / unclassified